Trifluridine

3 trials 1 recruiting LOncology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

7 Countries

Phase III

Phase II

Phase III: 1 Phase II: 2

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Colon cancer stage II 1 Colon cancer stage III 1

Sponsors using this IMP

Association Gercor 1 Gruppo Oncologico Del Nord Ovest 1 Merck Sharp & Dohme LLC 1

All trials

3 total

BEvacizumab plus Trifluridine/tipiracil in a bi-WEEkly administration to reduce grade 3-4 Neutropenia in patients with mCRC: A prospective, … Recruiting

2024-520128-27-00 Phase II 1 country Association Gercor
A clinical study of MK-2870 in people with stomach cancer (MK-2870-015) Ended

2023-505423-31-00 Phase III 7 countries Merck Sharp & Dohme LLC
Use of circulating tumor dna test to intensify post-operative treatment of patients with resected colon cancer. Halted

2024-515152-20-00 Phase II 1 country Gruppo Oncologico Del Nord Ovest

Showing 1–3 of 3 trials

← All drugs A–Z